Telemedicine for Diabetic Retinopathy Screening
Author Information
Author(s): Barbieri Vanessa de O. Almeida, Nakayama Luis Filipe, Barbieri Gabriel Almeida, da Silva Suzane Eberhart Ribeiro, Karmouche Daniel Cunha José, Shinzato Marcelle Naomi Oshiro, Nakagawa Rodrigo Eiji, Regatieri Caio Vinicius, Malerbi Fernando Korn
Primary Institution: Hospital São Julião, Campo Grande, MS, Brazil
Hypothesis
Can a telemedicine approach reduce waiting times for diabetic retinopathy specialist evaluations compared to in-person strategies?
Conclusion
The telemedicine approach significantly reduced the waiting time for specialist evaluation in a real-world setting.
Supporting Evidence
- The telemedicine group had a significantly shorter waiting time of 158.8 days compared to 292.3 days for the in-person group.
- Referral rates were lower in the telemedicine group at 29.38% compared to 73.29% in the in-person group.
- Patients in the telemedicine group had a mean diabetes duration of 11.99 years, significantly less than the in-person group's 17.28 years.
Takeaway
Using telemedicine to check for eye problems in diabetes patients means they wait less time to see a doctor.
Methodology
This retrospective study compared telemedicine and in-person diabetic retinopathy screening approaches.
Potential Biases
The traditional strategy group included patients with more severe diseases, which may have introduced bias.
Limitations
The study groups were not homogenous, and the analysis may have been influenced by the COVID-19 pandemic.
Participant Demographics
Mean age: 62.5 years; 61.7% female; mean diabetes duration: 15.3 years; 67.8% insulin users.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website